ABHD11 | Abhydrolase domain containing 11 | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
ABTB1 | Ankyrin repeat and BTB (POZ) domain containing 1 | Predicted intracellular proteins
| | | | | Expressed in all |
ABTB2 | Ankyrin repeat and BTB (POZ) domain containing 2 | Predicted intracellular proteins
| | | | | Mixed |
ACOXL | Acyl-CoA oxidase-like | Predicted intracellular proteins
| | | | | Group enriched |
AHRR | Aryl-hydrocarbon receptor repressor | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
AIM1L | Absent in melanoma 1-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKNAD1 | AKNA domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD34A | Ankyrin repeat domain 34A | Predicted intracellular proteins
| | | | | Tissue enriched |
ANKRD37 | Ankyrin repeat domain 37 | Predicted intracellular proteins
| | | | | Expressed in all |
APOL4 | Apolipoprotein L, 4 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
APOLD1 | Apolipoprotein L domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ARHGAP40 | Rho GTPase activating protein 40 | Predicted intracellular proteins
| | | | | Group enriched |
ARHGEF33 | Rho guanine nucleotide exchange factor (GEF) 33 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARMCX6 | Armadillo repeat containing, X-linked 6 | Predicted membrane proteins
| | | | | Expressed in all |
ATG16L2 | Autophagy related 16-like 2 (S. cerevisiae) | Predicted intracellular proteins
| | | | | Expressed in all |
ATP10D | ATPase, class V, type 10D | Enzymes Predicted membrane proteins
| | | | | Mixed |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
BAALC | Brain and acute leukemia, cytoplasmic | Predicted intracellular proteins
| | | | | Tissue enriched |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BARHL2 | BarH-like homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
BTBD3 | BTB (POZ) domain containing 3 | Predicted intracellular proteins
| | | | | Expressed in all |
BTBD8 | BTB (POZ) domain containing 8 | Predicted intracellular proteins
| | | | | Mixed |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C11orf1 | Chromosome 11 open reading frame 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C11orf49 | Chromosome 11 open reading frame 49 | Predicted intracellular proteins
| | | | | Expressed in all |
C11orf52 | Chromosome 11 open reading frame 52 | Predicted intracellular proteins
| | | | | Mixed |
C11orf63 | Chromosome 11 open reading frame 63 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C12orf66 | Chromosome 12 open reading frame 66 | Predicted intracellular proteins
| | | | | Expressed in all |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| | | | | Tissue enhanced |
C16orf46 | Chromosome 16 open reading frame 46 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C16orf93 | Chromosome 16 open reading frame 93 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C18orf54 | Chromosome 18 open reading frame 54 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C19orf44 | Chromosome 19 open reading frame 44 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf110 | Chromosome 1 open reading frame 110 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf159 | Chromosome 1 open reading frame 159 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
C1orf56 | Chromosome 1 open reading frame 56 | Predicted secreted proteins
| | | | | Tissue enriched |
C1orf74 | Chromosome 1 open reading frame 74 | Predicted intracellular proteins
| | | | | Mixed |
C21orf58 | Chromosome 21 open reading frame 58 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C2orf42 | Chromosome 2 open reading frame 42 | Predicted intracellular proteins
| | | | | Expressed in all |
C2orf81 | Chromosome 2 open reading frame 81 | Predicted intracellular proteins
| | | | | Group enriched |
C4orf19 | Chromosome 4 open reading frame 19 | Predicted intracellular proteins
| | | | | Mixed |
C6orf47 | Chromosome 6 open reading frame 47 | Predicted membrane proteins
| | | | | Expressed in all |
C8orf34 | Chromosome 8 open reading frame 34 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C8orf44 | Chromosome 8 open reading frame 44 | Predicted intracellular proteins
| | | | | Mixed |
C9orf117 | Chromosome 9 open reading frame 117 | Predicted intracellular proteins
| | | | | Tissue enriched |
C9orf152 | Chromosome 9 open reading frame 152 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | Predicted intracellular proteins
| | | | | Group enriched |